Carpal Tunnel Syndrome Clinical Trial
Official title:
Efficacy of Ultrasound-guided Peripheral Nerve Block Versus Forearm Bier's Block in Patients Undergoing Carpal Tunnel Release: A Randomized Controlled Trial
By means of an observer-blinded, randomized controlled trial, the analgesic efficacy of the
forearm intravenous regional anesthesia and the ultrasound guided peripheral nerve block will
be investigated in patients undergoing carpal tunnel release. The hypothesis is that the
ultrasound-guided peripheral nerve block is superior compared to the forearm intravenous
regional anesthesia with respect to the analgesic efficacy.
Furthermore, pre-, intra-, and post-operative pain will be investigated at several time
points as well as general patient satisfaction and satisfaction of the surgeon regarding the
procedures.
Introduction:
In Belgium, several ways of anesthesia are used to perform hand surgery, being general
anesthesia, intravenous regional anesthesia as well as locoregional anesthesia. Locoregional
anesthesia and intravenous regional anesthesia are often performed since patients can be
discharged from the hospital more rapidly. A forearm intravenous regional anesthesia (IVRA;
mini-Bier's block) is an effective and safe technique to perform hand surgery, especially
since the dose of the used anesthetic is reduced compared to a regular upper arm Bier's
block, leading to a reduced risk of local anesthetic toxicity. An ultrasound-guided distal
peripheral nerve block is often used for hand surgery, in which the nervus medianus and the
nervus ulnaris can be affected locally. Research showed that this technique is associated
with a reduced surgical procedure time when compared to intravenous regional anesthesia (1).
In the Jessa Hospital, a carpal tunnel release is often performed using the forearm
intravenous regional anesthesia. However, to date, the analeptic effectivity of the forearm
intravenous regional anesthesia has not been compared to the distal peripheral nerve block.
Outcome measures:
The primary aim of this study is to compare the analgesic effectivity of the forearm
intravenous regional anesthesia versus the ultrasound-guided distal peripheral nerve block.
Our hypothesis is that the latter technique is superior. A blinded surgeon will determine the
analgesic effectivity of these techniques (graded as "complete" or "incomplete") and divide
the effectivity in 4 grades. Grade 1 and grade 2 are considered "complete" blockade, while
grade 3 and grade 4 are considered "incomplete" blockade. Grade 1: complete motor and sensory
blockade, grade 2: partial motor blockade but no pain or deep pressure sensitivity, grade 3:
partial motor blockade with mild pain requiring rescue local or opioid analgesia, grade 4:
incomplete motor- and sensory blockade requiring sedation/conversion to general anesthesia).
Secondary study outcomes are patient's pre-, intra-, and post-operative pain scores at
several time points, measured via an 11-point Numeric Rating Scale (NRS) in which number 0
means "no pain at all", number 5 means "moderate pain" and number 10 means "worst possible
pain". General patient satisfaction as well as satisfaction of the surgeon regarding the used
technique will be measured via a 7-point Likert Scale, in which number 1 means "extremely
dissatisfied" and number 7 means "extremely satisfied". Furthermore, the time spend in the
operating room, the time of surgical procedure and the use of post-operative medication use
will be recorded as well.
Design:
In this monocentric, investigator-initiated, observer-blinded, prospective, randomized
controlled trial, 2 groups of patients that will undergo carpal tunnel release surgery will
be compared. This study will be performed according to the Declaration of Helsinki and will
be approved by the Ethical Committee of the Jessa Hospital before the start of the study. A
written informed consent will be obtained before participation in the study. Randomization
will be performed using a computer-generated random allocation sequence, created by the study
statistician. Allocation numbers will be sealed in opaque envelopes, which will be opened in
sequence by an independent anaesthesiologist who is not involved in the assessment of
outcomes.
Study Procedures:
The patient will first receive information about this study during the consultation with the
surgeon. After having ample amount of time to consider participation and before the start of
the study, written informed consent will be obtained. Afterwards, the patient will be
randomized to one of the 2 study groups. All anesthesia techniques will be performed by only
2 anaesthesiologists, to reduce the inter-individual difference in anaesthesia. All patients
will receive an intravenous catheter, supplementary oxygen and standard monitoring
(non-invasive blood pressure, electrocardiogram and saturation measurements).
Forearm intravenous regional anesthesia:
An intravenous catheter will be placed in the dorsal vein of the hand that will undergo
surgery. Also, a tourniquet will be placed on the forearm, after which the anesthetic can be
administered via the dorsal vein catether (25ml linisol 0.5%).
Distal peripheral nerve block:
For the distal peripheral nerve block, a General Electric LOGIQe device and a 12 MHz lineair
echotransducer with a foot of 4 cm will be used to locate the nervus medianus and the nervus
ulnaris. In total, 10ml linisol 2% will be used to affect the nerves (3ml linisol 2% around
the nervus medianus, 3ml linisol 2% around the nervus ulnaris and 4ml linisol 2% around the
peripheral distal nerves).
The surgeon and the researcher will be blinded for the used type of anaesthesia. To reduce a
possible deblinding, all patients receive a catheter in the dorsal vein of the hand that will
undergo surgery and all patients will receive disinfection on the specific locations on the
arm where the ultrasound-guided peripheral nerve block would be performed. In that way, both
surgeon and researcher are blinded. Before the start of the surgery, the surgeon will assess
the quality of the block (primary outcome) in the nervus ulnaris and nervus medianus, using a
forceps. The quality of the block will be graded "complete" (grade 1 and grade 2) or
"incomplete" (grade 3 or grade 4). In case of grade 1 or grade 2, the surgical procedure can
start. In case of grade 3, the blockade will be enhanced (local anesthetic for peripheral
nerve block or intravenous opioid administration (alfentanil or sufentanil) for IVRA). In
case of grade 4, sedation/conversion to general anesthesia will be performed. Per-operative
paracetamol administration 15mg/kg (max 1gram) and taradyl 0.5mg/kg (max 30mg) will be
supplied (except when there are contraindications). All patients (both distal peripheral
nerve block and IVRA) will receive dexamethasone 0.1mg/kg (max 5mg) (except when there are
contraindications) due to the positive effect of dexamethasone on the extension of the
locoregional anesthesia and the prevention of post-operative nausea and vomiting. All
secondary outcome measures will be investigated by the blinded researcher via questioning the
patient's pain scores (measured via an Numeric Rating Scale) at several time points before,
during and after surgery, and the satisfaction of both patient and surgeon (measured via a
7-point Likert Scale). Post-operative pain medication in the hospital includes paracetamol
15mg/kg (max 1gr) 1x/6h and taradyl 0.5mg/kg (max 30mg) 1x/8h, while contramal serves as
rescue medication. Post-operative pain medication at home includes paracetamol 15mg/kg (max
1gr) 1x/6h or ibuprofen 600mg 1x/8h whenever necessary. On day 1 after surgery, the patient
will be contacted via telephone by the researcher who will question the use of post-operative
pain medication, as well as NRS pain scores and patient satisfaction.
Statistical analysis:
Sample size was determined for the primary study outcome with the aim to reject the
superiority of the distal peripheral nerve block compared to forearm intravenous regional
anesthesia. Based on a retrospective analysis of unpublished data from our hospital, we
assume that 75% of patients will have a complete block (grade 1 or2) after a forearm IVRA.
Based on a previous study, we assume that 95% of patients will have a complete block (grade 1
or 2) after a distal peripheral nerve block (2). By using a binary outcome, we determined the
sample size for each group to be 47 (α=0.05, power=0.80). To account for a possible 6%
drop-out rate, the sample size was increased to 50 patients per group. Descriptive statistics
will be presented as frequencies and percentages of the total amount of patients for
categorical variables, while numerical variables will be presented as mean ± SD. Group
comparison will be performed using Chi-square test (or a Fisher's Exact test when necessary)
for frequencies. Depending on normality, a Mann-Witney U test or a Student's t-test will be
used and a Mixed-model analysis will be used to correct for the multiple measurements of the
Numerical Rating Scale (NRS) for pain scores. An average difference of 1.3 points or more on
the NRS pain score is considered clinical relevant. A p-value <0.05 is considered statistical
significant, while p<0.10 is considered a tendency.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05067205 -
Minimal Invasive Carpal Tunnel Release With the Novel Device
|
N/A | |
Completed |
NCT03184688 -
Platelet Rich Plasma for Carpal Tunnel Syndrome
|
N/A | |
Completed |
NCT03582735 -
Preoperative Neuromobilization Exercises for Individuals With Carpal Tunnel Syndrome
|
N/A | |
Completed |
NCT05490420 -
Effects of Upper Extremity Manual Lymphatic Drainage on Symptom Severity, Hand Functions, Electrophysiological and Ultrasonographic Measurements in Carpal Tunnel Syndrome
|
N/A | |
Recruiting |
NCT05970692 -
Cross-Cultural Adaptation and Psychometric Validation of the Turkish Version of Atroshi-Lyrén 6-item Symptoms Scale
|
||
Completed |
NCT04043780 -
Clinical Validation of a Decompression Prototype Splint for Patients With Carpal Tunel Syndrome
|
N/A | |
Completed |
NCT03880812 -
Cost Information on Carpal Tunnel Syndrome Treatment Decisions
|
N/A | |
Completed |
NCT06464809 -
Treatment Intervention of Patients With Carpal Tunnel Syndrome (CTS)
|
N/A | |
Recruiting |
NCT05503719 -
An Absorbable Suture Versus a Non-absorbable Suture in Carpal Tunnel Release, a Randomized Controlled Trial
|
N/A | |
Recruiting |
NCT05328180 -
aDjunct bicarbonatE in Local anaesthesIa for CarpAl Tunnel rElease (DELICATE)
|
N/A | |
Recruiting |
NCT05372393 -
Carpal Tunnel Release Under Local Anaesthesia With or Without Distal Median Nerve Block
|
N/A | |
Recruiting |
NCT05466162 -
Soft Tissue Massage Along With Mobilization Technique on Symptoms and Functional Status of Carpal Tunnel Syndrome
|
N/A | |
Completed |
NCT04060875 -
Research Protocol for Karuna Labs Inc.: Safety and Efficacy of Virtual Reality Graded Motor Imagery for Chronic Pain
|
||
Not yet recruiting |
NCT06294821 -
4AP to Delay Carpal Tunnel Release (CTR)
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT04328805 -
Pain Reduction and Changes in Upper Limb Function Produced by an Ibuprofen Treatment in Carpal Tunnel Syndrome.
|
Phase 4 | |
Terminated |
NCT02791529 -
Scalpel Versus Electrocautery for Surgical Skin Incision in Open Carpal Tunnel Release
|
Phase 1 | |
Completed |
NCT02141035 -
Acetyl-l-carnitine to Enhance Nerve Regeneration in Carpal Tunnel Syndrome
|
Phase 2/Phase 3 | |
Completed |
NCT01887145 -
Comparison of Long-term Outcomes Following Endoscopic or Open Surgery for Carpal Tunnel Syndrome
|
N/A | |
Recruiting |
NCT01897272 -
Post-Operative Splinting After Short-Incision Carpal Tunnel Release: a Prospective Study
|
N/A | |
Completed |
NCT01394822 -
Neuromuscular Ultrasound for Focal Neuropathies
|
N/A |